Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India

Cancer

Volumn 116, Issue 13, 2010, Pages 3160-3169

  Srivastava, Kshitij ^a   Srivastava, Anvesha ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DNA repair; Gallbladder cancer; Gallbladder carcinogenesis; Genetics; Polymerase chain reaction restriction fragment length polymorphism; Polymorphism

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CYSTEINE; GLUTAMINE; LYSINE; SERINE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; ERCC2 GENE; FEMALE; GALLBLADDER CANCER; GENE INTERACTION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC STABILITY; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MSH2 GENE; OGG1 GENE; ONCOGENE; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; FEMALE; GALLBLADDER NEOPLASMS; GALLSTONES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 77954300302     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25063     Document Type: Article

References (51)

1. Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun. 1989;7:121-128. (Pubitemid 19281959)
2. Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 1990;4:2587-2597. (Pubitemid 20188984)
3. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349-364. (Pubitemid 34232782)
4. Yoshida S, Todoroki T, Ichikawa Y, et al. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res. 1995;55:2756-2760.
5. Ajiki T, Fujimori T, Onoyama H, et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut. 1996;38:426-429. (Pubitemid 26074323)
6. Fujii K, Yokozaki H, Yasui W, et al. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers Prev. 1996;5:461-466. (Pubitemid 26182661)
7. Hanada K, Itoh M, Fujii K, et al. TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. Eur J Cancer. 1997;33:1136-1140.
8. Kohno T, Shinmura K, Tosaka M, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219-3225. (Pubitemid 28330419)
9. Jiao X, Huang J, Wu S, et al. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int J Cancer. 2007;121:501-505. (Pubitemid 46986481)
10. Sanguansin S, Petmitr S, Punyarit P, Vorasubin V, Weerapradist W, Surarit R. hMSH2 gene alterations associated with recurrence of oral squamous cell carcinoma. J Exp Clin Cancer Res. 2006;25:251-257. (Pubitemid 44113871)
11. Bernard-Gallon D, Bosviel R, Delort L, et al. DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer. 2008;7:36.
12. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002;17:463-469. (Pubitemid 35414774)
13. Beahrs OH. The American Joint Committee on Cancer. Bull Am Coll Surg. 1984;69:16-17.
14. Srivastava K, Srivastava A, Pandey S, Kumar A, Mittal B. Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J Gastroenterol. 2009;44:774-780.
15. Devlin B, Roeder K. Genomic Control for Association Studies. Biometrics. 1999;55:997-1004.
16. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.
17. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434-442. (Pubitemid 38443646)
18. Steinberg D, Colla P. CART: Tree-Structured Non-Parametric Data Analysis. San Diego, CA: Salford Systems; 1995.
19. Breiman L, Friedman J, Olshen R, Stone C. Classification and Regression Trees. Pacific Grove, CA: Wadsworth; 1984.
20. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863-874. (Pubitemid 32447869)
21. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894-3900. (Pubitemid 35012462)
22. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812-3814. (Pubitemid 37442253)
23. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics. 2004;83:970-979. (Pubitemid 38726046)
24. Schafmayer C, Buch S, Egberts JH, et al. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 2007;121:555-558.
25. Le Morvan V, Longy M, Bonaiti-Pellie C, et al. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients. Int J Cancer. 2006;119:1732-1735.
26. Park J, Chen L, Tockman MS, Elahi A, Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics. 2004;14:103-109. (Pubitemid 38253645)
27. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001;61:1354-1357. (Pubitemid 34292555)
28. Qiao Y, Spitz MR, Shen H, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis. 2002;23:295-299. (Pubitemid 34224005)
29. Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25:757-763.
30. Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis. 2002;23:599-603.
31. Coin F, Marinoni JC, Egly JM. Mutations in XPD helicase prevent its interaction and regulation by p44, another subunit of TFIIH, resulting in Xeroderma pigmentosum (XP) and trichothiodystrophy (TTD) phenotypes. Pathol Biol (Paris). 1998;46:679-680.
32. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306-309. (Pubitemid 33096456)
33. Hu Z, Wei Q, Wang X, Shen H. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer. 2004;46:1-10. (Pubitemid 39201378)
34. Benhamou S, Sarasin A. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol. 2005;161:1-14. (Pubitemid 40053274)
35. Li C, Hu Z, Liu Z, et al. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:2526-2532.
36. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res. 2005;577:275-283.
37. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002;62:2447-2454. (Pubitemid 34462716)
38. Simpkins SB, Bocker T, Swisher EM, et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic cancers. Hum Mutat Genet. 1999;8:661-666. (Pubitemid 29139981)
39. Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ. 2001;8:1076-1092. (Pubitemid 33061825)
40. Jung CY, Choi JE, Park JM, et al. Polymorphisms in the hMSH2 gene and the risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:762-768.
41. Poplawski T, Zadrozny M, Kolacinska A, Rykala J, Morawiec Z, Blasiak J. Polymorphisms of the DNA mismatch repair gene HMSH2 in breast cancer occurrence and progression. Breast Cancer Res Treat. 2005;94:199-204. (Pubitemid 41677624)
42. Marra G, D'Atri S, Corti C, et al. Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. Proc Natl Acad Sci U S A. 2001;98:7164-7169.
43. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-4878. (Pubitemid 24289415)
44. Kamiya H, Murata-Kamiya N, Koizume S, Inoue H, Nishimura S, Ohtsuka E. 8-Hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: effects of sequence contexts on mutation spectra. Carcinogenesis. 1995;16:883-889.
45. Srivastava A, Srivastava K, Pandey SN, Choudhuri G, Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population. Ann Surg Oncol. 2009;16:1695-1703.
46. Xing D, Tan W, Song N, Lin D. Genetic polymorphism in hOGG1 and susceptibility to esophageal cancer in Chinese [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2000;17:377-380. (Pubitemid 32098567)
47. Fan CY, Liu KL, Huang HY, et al. Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest. 2001;81:1429-1438.
48. Matullo G, Peluso M, Polidoro S, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev. 2003;12:674-677.
49. Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA. 1983;250:2323-2326.
50. Kapoor VK. Cholecystectomy in patients with asymptomatic gallstones to prevent gall bladder cancer - the case against. Indian J Gastroenterol. 2006;25:152-154.
51. Thomas-Ahner JM, Wulff BC, Tober KL, Kusewitt DF, Riggenbach JA, Oberyszyn TM. Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Res. 2007;67:3468-3474.